https://www.selleckchem.com/products/cddo-im.html
Currently, there is no independent risk assessment specifically established for patients with inflammatory arthritis. INFLUENCE OF ANTIRHEUMATIC DRUGS ON CARDIOVASCULAR RISK Antirheumatic drugs can modify cardiovascular risk. The most pronounced protective effect was found in biologics. Tumor necrosis factor α inhibitors, for instance, reduce cardiovascular event rate by 15 %. Data on methotrexate is less robust but also suggests a protective effect in patients with inflammatory arthritis. Studies on the relatively new janus kinase inhi
Curtir
Comentario
Compartilhar
